Study title: Open dose finding study on effects and tolerability of Egb 761 in children with attention deficit/hyperactovity syndrome (ADHS)
Type of medicine: Herbal and homoeopathic medicines | |||||
Therapeutic area: Mental Disorders [F03] | |||||
Brands: | |||||
MAH holders: | |||||
Assessment: | |||||
Active substance: Ginkgo biloba (herb)/ Ginkgo biloba leaves (35-67:1), (herb)/ HERB: 40 mg Ginkgo bilobae fol. extr. sicc. (35 - 67 : 1), corresponding to 9.6 mg ginkgo flavone glycosides and 2.4 mg terpene lactones./ HERB: Dry extract of Ginkgo biloba leaves 40 mg, standardized to 9.6 mg (24%) Ginkgo flavone glycosides and 2.4 mg (6%) terpene lactones (ginkgolides and bilobalide)./ HERB: extract (50:1) from Gi... | |||||
ATC code: N06DX02 | |||||
Document link: | |||||
Document date: 2011-10-19 | |||||
Study number: 523001.01.064 | |||||
EudraCT number: | |||||
Scope of study: CLINICAL | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |